Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 16, 2026 08:00 ET | Source: Cytokinetics, Incorporated

Cytokinetics Announces Four Presentations at the American College of Cardiology Annual Scientific Session & Expo

New Analyses from Three Trials in Obstructive HCM Support Findings from Previously Published Data on MYQORZO™ (aficamten) SOUTH SAN FRANCISCO, Calif., March 16, 2026 (GLOBE NEWSWIRE) --...
March 12, 2026 15:06 ET | Source: The Doctor's Book Of Survival Home Remedies

The Doctor's Book of Survival Home Remedies Claims Evaluated: 2026 Consumer Research Report Examining The Great Healthcare Reset by Dr. Herzog

Survivopedia's Doctor's Book of Survival Home Remedies evaluated: 2026 consumer research report examining herbal remedy research context and drug shortage
March 11, 2026 09:05 ET | Source: Ensemble Health Partners

Ensemble Announces Strategic Revenue Cycle Partnership with Stamford Health

CINCINNATI, Ohio, March 11, 2026 (GLOBE NEWSWIRE) -- Ensemble, the nation’s leading end-to-end revenue cycle managed services partner for healthcare organizations, announced today that it has been...
March 10, 2026 08:00 ET | Source: Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Presented Post Hoc Analyses of Phase 3 Data on TONMYATM at the 8th International Congress on Controversies in Fibromyalgia

Company launched TONMYA, approved by the FDA as a treatment for fibromyalgia, in November 2025 In post hoc analysis of the pivotal RESILIENT study, TONMYA produced rapid pain relief as early as Day 2...
March 10, 2026 06:00 ET | Source: Esperion Therapeutics, Inc.

Esperion Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

– FY25 Total Revenue Grew 21% Y/Y to $403.1 Million; FY25 U.S. Net Product Revenue Grew 38% Y/Y to $159.6 Million – – Q4 2025 U.S. Net Product Revenue Grew ~38% Y/Y to $43.7 Million; Q4 2025 Total...
March 09, 2026 16:30 ET | Source: Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Presented Data on TONMYA™ in Treating Patients with Fibromyalgia at the 2026 AAPM PainConnect Annual Meeting

TONMYA (cyclobenzaprine HCl sublingual tablets) for the treatment of fibromyalgia in adults, was commercially launched in November 2025Treatment with TONMYA provided statistically significant pain...
March 09, 2026 15:13 ET | Source: Global Virus Network

Global Virus Network opens International Headquarters at University of South Florida

Global Virus Network Ribbon Cutting Marks Official Opening of its International Headquarters at University of South Florida
March 09, 2026 12:53 ET | Source: Scripps Health

Modern Healthcare Names Scripps’ Dr. Ghazala Sharieff to List of Year’s Leading Women

San Diego, CA, March 09, 2026 (GLOBE NEWSWIRE) -- Modern Healthcare magazine has given one its 2026 Leading Women awards to Ghazala Sharieff, M.D., M.B.A., Scripps Health corporate executive vice...
March 06, 2026 07:30 ET | Source: TG Therapeutics, Inc.

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2026 Annual Meeting

NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI® (ublituximab-xiiy) data in patients...
March 05, 2026 16:15 ET | Source: Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Announces Publication of Clinical Pharmacokinetic Studies of TONMYA™ and Prototype Formulations in the Journal Clinical Pharmacology in Drug Development

Commercially launched in the U.S. in November 2025, TONMYA (cyclobenzaprine HCl sublingual tablets) for long-term daily dosing at bedtime is the first new FDA-approved treatment for fibromyalgia in...